+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Patient Controlled Analgesia"

From
Conventional and Alternative Pain Treatment Markets - Product Thumbnail Image

Conventional and Alternative Pain Treatment Markets

  • Report
  • November 2020
  • 260 Pages
  • Global
From
Postoperative Pain - Epidemiology Forecast - 2032 - Product Thumbnail Image

Postoperative Pain - Epidemiology Forecast - 2032

  • Drug Pipelines
  • March 2022
  • 162 Pages
  • Global
From
From
From
Pain Therapeutics - Drugs, Markets and Companies - Product Thumbnail Image

Pain Therapeutics - Drugs, Markets and Companies

  • Report
  • November 2021
  • 600 Pages
  • Global
From
  • 14 Results (Page 1 of 1)
Loading Indicator

Patient Controlled Analgesia (PCA) is a form of analgesic therapy that allows patients to self-administer medication to manage their pain. It is typically used in the hospital setting, and involves the patient using a device to deliver a predetermined dose of medication when needed. The device is programmed to deliver a certain amount of medication over a certain period of time, and the patient can press a button to receive an additional dose if needed. This allows the patient to have more control over their pain management, and can help reduce the risk of opioid-related side effects. The PCA market is a subset of the analgesics market, and is growing as more healthcare providers recognize the benefits of this type of therapy. Companies in this market include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, and Smiths Medical. Show Less Read more